Diopolol Adverse Reactions



Mega Lifesciences


Full Prescribing Info
Adverse Reactions
Potential Adverse Reactions: A variety of adverse reactions not listed (see Side Effects) have been reported with other beta-adrenergic blocking agents and should be considered potential adverse reactions to bisoprolol extended release tablets.
Central Nervous System: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation for time and place, short term memory loss, emotional lability, slightly clouded sensorium, and decreased performance on neuropsychometrics.
Cardiovascular: Intensification of AV block.
Hematologic: Agranulocytosis, nonthrombocytopenic purpura, thrombocytopenic purpura.
Heart Failure: In the MERIT-HF study, serious adverse events and adverse events leading to discontinuation of study medication were systematically collected. Following are the adverse events in the MERIT-HF study that occurred at an incidence of equal to or greater than 1% in the bisoprolol extended release tablets group and greater than placebo by more than 0.5%, regardless of the assessment of causality: Dizziness/vertigo, bradycardia, accident and/or injury.
Other adverse events with an incidence of >1% on bisoprolol extended release tablets and as common on placebo (within 0.5%) included myocardial infarction, pneumonia, cerebrovascular disorder, chest pain, dyspnea/dyspnea aggravated, syncope, coronary artery disorder, ventricular tachycardia/arrhythmia aggravated, hypotension, diabetes mellitus/diabetes mellitus aggravated, abdominal pain, and fatigue.
It is advised to inform to doctor of any adverse reaction suffered from using this drug.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in